Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Biotie Therapies Corp.
Type
Publicly traded
Traded as OMX: BTH1V
Industry Biotechnology
Founded 1998
Headquarters Turku, Finland
Key people
Timo Veromaa (CEO), Peter Fellner (Chairman of the Board)
Revenue Increase € 4.8 million (2012)
Operating income
Increase (€25.6 million) (2012)
Number of employees
38 (end 2012)
Website Biotie.com

Biotie Therapies is a Finnish biotechnology and pharmaceutics company. The company's research and development is focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki.

Investment goal date:
Dividends reinvested
Biotie Therapies Corp. BITI report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks